TY  - JOUR
AU  - Pérez-Martínez, Laura
AU  - Romero, Lourdes
AU  - Muñoz-Galván, Sandra
AU  - Verdugo-Sivianes, Eva M
AU  - Rubio-Mediavilla, Susana
AU  - Oteo, José A
AU  - Carnero, Amancio
AU  - Blanco, José-Ramón
PY  - 2020
DO  - 10.18632/aging.103167
UR  - http://hdl.handle.net/10668/15471
T2  - Aging
AB  - As age increases, the risk of developing fragility also increases. Improving the knowledge of frailty could contribute to maintaining the functional ability of elderly people. Interleukin (IL)-10 homozygous knockout mice (IL-10tm/tm [IL10KO])...
LA  - en
KW  - CCR5 antagonist
KW  - frailty
KW  - myostatin
KW  - rapamycin
KW  - Aging
KW  - Animals
KW  - Cytokines
KW  - Disease Models, Animal
KW  - Frailty
KW  - Interleukin-10
KW  - Male
KW  - Maraviroc
KW  - Mice
KW  - Mice, Knockout
KW  - Muscle, Skeletal
KW  - Random Allocation
KW  - Receptors, Chemokine
KW  - Sirolimus
KW  - Survival Rate
TI  - Implications of maraviroc and/or rapamycin in a mouse model of fragility.
TY  - research article
VL  - 12
ER  -